Immediate and long-term consequences of COVID-19 infections for the development of neurological disease

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884

COVID-19: consider cytokine storm syndromes and immunosuppression

Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664

Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China

Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166

Clinical and immunological features of severe and moderate coronavirus disease 2019

Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750

NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice

Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898

Neurologic features in severe SARS-CoV-2 infection

Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., Collange, O., Boulay, C., Fafi-Kremer, S., Ohana, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2008597 · Cited by 2,674

Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study

Lechien, J. R., Chiesa-Estomba, C. M., De Siati, D. R., Horoi, M., Le Bon, S. D., Rodriguez, A., Dequanter, D., Blecic, S., El Afia, F., Distinguin, L., et al. (2020) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-020-05965-1 · Cited by 2,668 · cited 1×

Long-term cognitive impairment and functional disability among survivors of severe sepsis.

Iwashyna, T. J., Ely, E. W., Smith, D. M., & Langa, K. M. (2010) · JAMA · doi:10.1001/jama.2010.1553 · Cited by 2,582

Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis

Rodriguez-Morales, A. J., Cardona-Ospina, J. A., Gutiérrez-Ocampo, E., Villamizar-Peña, R., Holguin-Rivera, Y., Escalera-Antezana, J. P., Alvarado-Arnez, L. E., Bonilla-Aldana, D. K., Franco-Paredes, C., Henao-Martinez, A. F., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101623 · Cited by 2,542

Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young

Oxley, T. J., Mocco, J., Majidi, S., Kellner, C. P., Shoirah, H., Singh, I. P., Leacy, R. A. D., Shigematsu, T., Ladner, T. R., Yaeger, K., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009787 · Cited by 2,114

SARS-CoV-2-Mediated Neuropathogenesis, Deterioration of Hippocampal Neurogenesis and Dementia

Radhakrishnan, R. K., & Kandasamy, M. (2022) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175221078418 · Cited by 35

Post-COVID-19 Syndrome Mechanisms, Prevention and Management

Najafi, M. B., & Javanmard, S. (2023) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_508_21 · Cited by 38

Lactoferrin for Mental Health: Neuro-Redox Regulation and Neuroprotective Effects across the Blood-Brain Barrier with Special Reference to Neuro-COVID-19

Naidu, S. A. G., Wallace, T. C., Davies, K. J. A., & Naidu, A. S. (2021) · Journal of Dietary Supplements · doi:10.1080/19390211.2021.1922567 · Cited by 35

Dissecting the Molecular Mechanisms Surrounding Post-COVID-19 Syndrome and Neurological Features

Mohamed, M. S., Johansson, A., Jonsson, J., & Schiöth, H. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084275 · Cited by 37

COVID-19 and long-term neurological problems: Challenges ahead with Post-COVID-19 Neurological Syndrome

Wijeratne, T., & Crewther, S. G. (2021) · Australian Journal of General Practice · doi:10.31128/ajgp-covid-43 · Cited by 35

Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS

Szabo, M. P., Iba, M., Nath, A., Masliah, E., & Kim, C. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00755-7 · Cited by 37

SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t

Lingor, P., Demleitner, A. F., Wolff, A. W., & Feneberg, E. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02500-w · Cited by 37

A comprehensive review on clinical and mechanistic pathophysiological aspects of COVID-19 Malady: How far have we come?

Shakaib, B., Zohra, T., Ikram, A., Shakaib, M. B., Ali, A. A. A., Bashir, A., Salman, M., Khan, M. A., & Ansari, J. A. (2021) · Virology Journal · doi:10.1186/s12985-021-01578-0 · Cited by 34

Coronavirus disease 2019 and neurodegenerative disease: what will the future bring?

McAlpine, L. S., Fesharaki‐Zadeh, A., & Spudich, S. (2020) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000688 · Cited by 36

Optimizing Healthcare Through Digital Health and Wellness Solutions to Meet the Needs of Patients With Chronic Disease During the COVID-19 Era

Seixas, A. A., Olaye, I. M., Wall, S. P., & Dunn, P. J. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.667654 · Cited by 39

Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond

Faist, A., Janowski, J., Kumar, S., Hinse, S., Çalışkan, D. M., Lange, J., Ludwig, S., & Brunotte, L. (2022) · Cells · doi:10.3390/cells11142198 · Cited by 31

Amyloid precursor protein facilitates SARS-CoV-2 virus entry into cells and enhances amyloid-β-associated pathology in APP/PS1 mouse model of Alzheimer’s disease

Chen, J., Chen, J., Lei, Z., Zhang, F., Zeng, L., Wu, X., Li, S., & Tan, J. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02692-z · Cited by 33

Microbiota-Gut-Brain Communication in the SARS-CoV-2 Infection

Manosso, L. M., Arent, C. O., Borba, L. A., Ceretta, L. B., Quevedo, J., & Réus, G. Z. (2021) · Cells · doi:10.3390/cells10081993 · Cited by 36

COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences

Baazaoui, N., & Iqbal, K. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220105 · Cited by 35

Long-COVID: Cognitive deficits (brain fog) and brain lesions in non–hospitalized patients

Hugon, J. (2021) · La Presse Médicale · doi:10.1016/j.lpm.2021.104090 · Cited by 34

Cellular and Molecular Effects of SARS-CoV-2 Linking Lung Infection to the Brain

Francistiová, L., Klepe, A., Curley, G., Gulya, K., Dinnyés, A., & Filkor, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.730088 · Cited by 36

Can SARS-CoV-2 Infection Exacerbate Alzheimer’s Disease? An Overview of Shared Risk Factors and Pathogenetic Mechanisms

Villa, C., Rivellini, E., Lavitrano, M., & Combi, R. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12010029 · Cited by 34

Aged brain and neuroimmune responses to COVID-19: post-acute sequelae and modulatory effects of behavioral and nutritional interventions

Müller, L., & Benedetto, S. D. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00341-z · Cited by 31

Direct and indirect neurological manifestations of COVID-19

Громова, О. А., Torshin, I. Y., Semenov, V. A., Putilina, M. V., & Chuchalin, A. G. (2020) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202012011111 · Cited by 30

Infection and Immunometabolism in the Central Nervous System: A Possible Mechanistic Link Between Metabolic Imbalance and Dementia

Shinjyo, N., & Kita, K. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.765217 · Cited by 29

SARS-CoV-2 impairs the disassembly of stress granules and promotes ALS-associated amyloid aggregation

Li, Y., Lu, S., Gu, J., Xia, W., Zhang, S., Zhang, S., Wang, Y., Zhang, C., Sun, Y., Lei, J., et al. (2022) · Protein & Cell · doi:10.1007/s13238-022-00905-7 · Cited by 30

COVID-19: a new emerging respiratory disease from the neurological perspective

El-Sayed, A., Aleya, L., & Kamel, M. S. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-12969-9 · Cited by 30

Dementia Risk among Coronavirus Disease Survivors: A Nationwide Cohort Study in South Korea

Park, H.-Y., Song, I., & Oh, T.-K. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11101015 · Cited by 31

Acute ischemic stroke and vaccine-induced immune thrombotic thrombocytopenia post COVID-19 vaccination; a systematic review

Kolahchi, Z., Khanmirzaei, M., & Mowla, A. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120327 · Cited by 32

Impact of the Renin-Angiotensin System on the Pathogeny and Pharmacotherapeutics of Neurodegenerative Diseases

Bild, W., Vasincu, A., Rusu, R.-N., Ababei, D. C., Stana, B. A., Stanciu, G. D., Savu, B., & Bild, V. (2022) · Biomolecules · doi:10.3390/biom12101429 · Cited by 32

Brain Volume Changes after COVID-19 Compared to Healthy Controls by Artificial Intelligence-Based MRI Volumetry

Bendella, Z., Widmann, C. N., Layer, J. P., Layer, Y. L., Haase, R., Sauer, M., Bieler, L., Lehnen, N. C., Paech, D., Heneka, M. T., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13101716 · Cited by 29

The unfolding palette of COVID-19 multisystemic syndrome and its neurological manifestations

Barrantes, F. J. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100251 · Cited by 29

Cinnamon and Hop Extracts as Potential Immunomodulators for Severe COVID-19 Cases

Lucas, K., Fröhlich‐Nowoisky, J., Oppitz, N., & Ackermann, M. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.589783 · Cited by 28

Endothelial dysfunction in COVID- 19 and cognitive impairment

Martynov, M. Y., Bogolepova, A. N., & Yasamanova, A. N. (2021) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202112106193 · Cited by 32

Genetic Exchange of Lung-Derived Exosome to Brain Causing Neuronal Changes on COVID-19 Infection

Ahmed, S. S. S. J., Paramasivam, P., Kamath, S. M., Sharma, A. K., Rome, S., & Murugesan, R. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02485-9 · Cited by 29

Olfactory Training in Post-COVID-19 Persistent Olfactory Disorders: Value Normalization for Threshold but Not Identification

Vandersteen, C., Payne, M., Dumas, L.-É., Cancian, É., Plonka, A., D’Andréa, G., Chirio, D., Demonchy, É., Risso, K., Askenazy-Gittard, F., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123275 · Cited by 31

COVID-19 im Alter – Die geriatrische Perspektive

Wirth, R., Becker, C., Djukic, M., Drebenstedt, C., Heppner, H. J., Jacobs, A. H., Meisel, M., Michels, G., Nau, R., Pantel, J., et al. (2021) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-021-01864-0 · Cited by 30

Chronic neuropsychiatric sequelae of SARS‐CoV‐2: Protocol and methods from the Alzheimer's Association Global Consortium

de Erausquin, G. A., Snyder, H. M., Brugha, T. S., Seshadri, S. S., Carrillo, M. C., Sagar, R., Huang, Y., Newton, C. R. J. C., Tartaglia, M. C., Teunissen, C. E., et al. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12348 · Cited by 27

Neurological and mental health consequences of COVID-19: potential implications for well-being and labour force

Meier, I. B., Teixeira, C. V. L., Tarnanas, I., Mirza, F., & Rajendran, L. (2021) · Brain Communications · doi:10.1093/braincomms/fcab012 · Cited by 26

Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication

Hügle, B., Krumrey-Langkammerer, M., & Haas, J. (2021) · Pediatric Rheumatology · doi:10.1186/s12969-021-00653-8 · Cited by 26

Neuro-COVID-19: an insidious virus in action

Bratosiewicz‐Wąsik, J. (2021) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2021.0072 · Cited by 27

Targeting Macrophage Dysregulation for Viral Infections: Novel Targets for Immunomodulators

Reece, M. D., Taylor, R. R., Song, C., & Gavegnano, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.768695 · Cited by 26

Persistent COVID-19 syndrome. A narrative review

Sampalo, A. L., Bernal-López, M. R., & Gómez‐Huelgas, R. (2022) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2021.10.001 · Cited by 35

COVID-19 and the Brain: The Neuropathological Italian Experience on 33 Adult Autopsies

Fabbri, V. P., Riefolo, M., Lazzarotto, T., Gabrielli, L., Cenacchi, G., Gallo, C., Aspide, R., Frascaroli, G., Liguori, R., Lodi, R., et al. (2022) · Biomolecules · doi:10.3390/biom12050629 · Cited by 26

Implication of Aging Related Chronic Neuroinflammation on COVID-19 Pandemic

Bossù, P., Toppi, E., Sterbini, V., & Spalletta, G. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030102 · Cited by 25

Manifestations and mechanisms of central nervous system damage caused by SARS-CoV-2

Yang, F., Zhao, H., Liu, H., Wu, X., & Li, Y. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.09.015 · Cited by 24

Molecular and Clinical Prognostic Biomarkers of COVID-19 Severity and Persistence

Papadopoulou, G., Manoloudi, E., Repousi, N., Skoura, L., Hurst, T. P., & Karamitros, T. (2022) · Pathogens · doi:10.3390/pathogens11030311 · Cited by 25

Psychotic-like experiences during COVID-19 lockdown among adolescents: Prevalence, risk and protective factors

Wang, D., Zhou, L., Chen, C., & Sun, M. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.01.027 · Cited by 25

Clinical and pulmonary function analysis in long-COVID revealed that long-term pulmonary dysfunction is associated with vascular inflammation pathways and metabolic syndrome

Sanhueza, S., Vidal, M., Hernandez, M. A., Henríquez‐Beltrán, M., Cabrera, C., Quiroga, R. A., Antilef, B., Aguilar, K. P., Castillo, D. A., Llerena, F., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1271863 · Cited by 25

Age-related cognitive effects of the COVID-19 pandemic restrictions and associated mental health changes in Germans

Menze, I., Mueller, P., Mueller, N. G., & Schmicker, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-11283-9 · Cited by 27

Cognitive impact and brain structural changes in long COVID patients: a cross-sectional MRI study two years post infection in a cohort from Argentina

Cataldo, S. A., Micciulli, A., Margulis, L., Cibeyra, M., DEFEO, S., Horovitz, S. G., Martino, A., Melano, R., Mena, M., Parisi, F., et al. (2024) · BMC Neurology · doi:10.1186/s12883-024-03959-8 · Cited by 30

Therapeutic approaches for SARS-CoV-2 infection

Gupta, A., Pradhan, A., Maurya, V. K., Kumar, S., Theengh, A., Puri, B., & Saxena, S. K. (2021) · Methods · doi:10.1016/j.ymeth.2021.04.026 · Cited by 23

Mid-term Psychiatric Outcomes of Patients Recovered From COVID-19 From an Italian Cohort of Hospitalized Patients

Gramaglia, C. M., Gambaro, E., Bellan, M., Balbo, P. E., Baricich, A., Sainaghi, P. P., Pirisi, M., Baldon, G., Battistini, S., Binda, V., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.667385 · Cited by 23

Association of depression and COVID-induced PTSD with cognitive symptoms after COVID-19 illness

Liyanage-Don, N. A., Winawer, M. R., Hamberger, M. J., Agarwal, S., Trainor, A., Quispe, K. A., & Kronish, I. M. (2022) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2022.02.006 · Cited by 25

Cardiovascular, Pulmonary, and Neuropsychiatric Short- and Long-Term Complications of COVID-19

Kobusiak−Prokopowicz, M., Fułek, K., Fułek, M., Kaaz, K., Mysiak, A., Kurpas, D., Beszłej, J. A., Brzecka, A., & Leszek, J. (2022) · Cells · doi:10.3390/cells11233882 · Cited by 22

Long-Term effects of COVID-19: a review of current perspectives and mechanistic insights

Lenz, C., Slack, M., Shea, K. M., Reinert, R. R., Taysi, B. N., & Swerdlow, D. L. (2023) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2023.2190405 · Cited by 28

Frailty after COVID ‐19: The wave after?

König, M., Gollasch, M., & Komleva, Y. (2023) · Aging Medicine · doi:10.1002/agm2.12258 · Cited by 26

Post-COVID seizure: A new feature of “long-COVID”

Kincaid, K. J., Kung, J., Senetar, A. J., Mendoza, D., Bonnin, D. A., Purtlebaugh, W. L., Cabatbat, R. M., Dickens, R. R., Echevarría, F. D., Kariyawasam, V., et al. (2021) · eNeurologicalSci · doi:10.1016/j.ensci.2021.100340 · Cited by 24

Impact of SARS-CoV-2 Infection During Pregnancy on Infant Neurobehavioral Development: A Case-Control Study

Cheng, Y., Teng, H., Xiao, Y., Yao, M., Yin, J., & Sun, G. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.762684 · Cited by 24

Identifying cerebral microstructural changes in patients with COVID-19 using MRI

Alhazmi, F. H., Alsharif, W. M., Alshoabi, S. A., Gameraddin, M. B., Aloufi, K. M., Abdulaal, O. M., & Qurashi, A. A. (2023) · Brain Circulation · doi:10.4103/bc.bc_77_22 · Cited by 22

Cognitive impairment in post-acute COVID-19 syndrome: a scoping review

Cipolli, G. C., Alonso, V., Yasuda, C. L., de Assumpção, D., Cachioni, M., de Melo, R. C., Hinsliff‐Smith, K., & Yassuda, M. S. (2023) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0043-1777115 · Cited by 22

COVID-19, ferrosenescence and neurodegeneration, a mini-review

Sfera, A., Osorio, C. P., Maguire, G. A., Rahman, L., Jafri, A., Cummings, M. A., & Maldonado, J. C. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110230 · Cited by 21

Could SARS-CoV-2 cause tauopathy?

Pratt, J., Lester, E., & Parker, R. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00168-x · Cited by 21

Post-COVID syndrome: prevalence, organ pathogenesis and routes of correction. A systematic review

Канорский, С. Г. (2021) · Кубанский научный медицинский вестник · doi:10.25207/1608-6228-2021-28-6-90-116 · Cited by 30

Symptoms and quality of life at 1-year follow up of patients discharged after an acute COVID-19 episode

Tessitore, E., Handgraaf, S., Poncet, A., Achard, M., Höfer, S., Carballo, S., Marti, C., Follonier, C., Girardin, F. R., Mach, F., et al. (2021) · Swiss Medical Weekly · doi:10.4414/smw.2021.w30093 · Cited by 21

The Role of the Gastrointestinal System in Neuroinvasion by SARS-CoV-2

Xu, J., Wu, Z., Zhang, M., Liu, S., Zhou, L., Yang, C., & Liu, C. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.694446 · Cited by 22

Neuroimmune multi-hit perspective of coronaviral infection

Hayley, S. P., & Sun, H. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02282-0 · Cited by 21

The multitaskers of the brain: glial responses to viral infections and associated post-infectious neurologic sequelae

Davé, V. A., & Klein, R. S. (2023) · Glia · doi:10.1002/glia.24294 · Cited by 29

Neuropsychiatric Manifestations of COVID-19 Disease and Post COVID Syndrome: The Role of N-acetylcysteine and Acetyl-L-carnitine

Barlattani, T., Celenza, G., Cavatassi, A., Minutillo, F., Socci, V., Pinci, C., Santini, R., & Pacitti, F. (2024) · Current Neuropharmacology · doi:10.2174/011570159x343115241030094848 · Cited by 20

The Intersection between COVID-19, the Gene Family of ACE2 and Alzheimer’s Disease

Haghighi, M. M., Kakhki, E. G., Sato, C., Ghani, M., & Rogaeva, E. A. (2020) · Neuroscience Insights · doi:10.1177/2633105520975743 · Cited by 20

Clinical and Radiological Deterioration in a Case of Creutzfeldt–Jakob Disease following SARS-CoV-2 Infection: Hints to Accelerated Age-Dependent Neurodegeneration

Ciolac, D., Racila, R., Duarte, C. L., Vasilieva, M., Diana, M., Nadejda, G., Condrea, A., Igor, C., Eremei, Z., Efremova, D., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9111730 · Cited by 20

Post-SARS-CoV-2 infection and post-vaccine-related neurological complications share clinical features and the same positivity to anti-ACE2 antibodies

Bellucci, M., Bozzano, F. M., Castellano, C., Pesce, G., Beronio, A., Hajabbas-Farshchi, A., Limongelli, A., Uccelli, A., Benedetti, L., & Maria, A. D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1398028 · Cited by 20

Nervous System Involvement in COVID-19: a Review of the Current Knowledge

Norouzi, M., Miar, P., Norouzi, S., & Nikpour, P. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02347-4 · Cited by 19

2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards

Bozkurt, B., Das, S. R., Addison, D., Gupta, A., Jneid, H. M., Khan, S. S., Koromia, G. A., Kulkarni, P. A., LaPoint, K., Lewis, E. F., et al. (2022) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/hcq.0000000000000111 · Cited by 21

Is the post-COVID-19 syndrome a severe impairment of acetylcholine-orchestrated neuromodulation that responds to nicotine administration?

Leitzke, M. (2023) · Bioelectronic Medicine · doi:10.1186/s42234-023-00104-7 · Cited by 30

Unravelling the connection between COVID-19 and Alzheimer’s disease: a comprehensive review

Shajahan, S. R., Kumar, S., & Ramli, M. D. C. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1274452 · Cited by 23

Evaluation of the xerostomia, taste and smell impairments after Covid-19

Omezli, M., & Torul, D. (2021) · Medicina oral, patología oral y cirugía bucal · doi:10.4317/medoral.24510 · Cited by 19

Commentary: APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort

Kasparian, K., Graykowski, D. R., & Cudaback, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01939 · Cited by 20

Risk of new-onset dementia following COVID-19 infection: a systematic review and meta-analysis

Zhang, Q., Botta, R., Xu, Y., Wei, J. C., & Tung, T. (2025) · Age and Ageing · doi:10.1093/ageing/afaf046 · Cited by 20

Longitudinal Neurocognitive and Pulmonological Profile of Long COVID-19: Protocol for the COVIMMUNE-Clin Study

Widmann, C. N., Wieberneit, M., Bieler, L., Bernsen, S., Gräfenkämper, R., Brosseron, F., Schmeel, F. C., Tacik, P. M., Skowasch, D., Radbruch, A., et al. (2021) · JMIR Research Protocols · doi:10.2196/30259 · Cited by 19

Small Fibre Peripheral Alterations Following COVID-19 Detected by Corneal Confocal Microscopy

Midena, E., Cosmo, E., Cattelan, A. M., Briani, C., Leoni, D., Capizzi, A., Tabacchi, V., Parrozzani, R., Midena, G., & Frizziero, L. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12040563 · Cited by 18

Panax ginseng as a potential therapeutic for neurological disorders associated with COVID-19; Toward targeting inflammasome

Shin, S. W., & Cho, I. H. (2022) · Journal of Ginseng Research · doi:10.1016/j.jgr.2022.09.004 · Cited by 19

Effect of COVID-19 on Musculoskeletal Performance in Gait and the Timed-Up and Go Test

Kowal, M., Morgiel, E., Winiarski, S., Gieysztor, E., Madej, M., Sebastian, A., Madziarski, M., Wedel, N., Proc, K., Madziarska, K., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134184 · Cited by 20

Serum Neurofilament Light is elevated in COVID-19 Positive Adults in the ICU and is associated with Co-Morbid Cardiovascular Disease, Neurological Complications, and Acuity of Illness

Hay, M., Ryan, L., Huentelman, M. J., Konhilas, J. P., Hoyer-Kimura, C. H., Beach, T. G., Serrano, G. E., Reiman, E. M., Blennow, K., Zetterberg, H., et al. (2021) · Cardiology and Cardiovascular Medicine · doi:10.26502/fccm.92920221 · Cited by 18

Functional outcomes and post‐discharge care sought by patients with COVID‐19 compared to matched controls after completing inpatient acute rehabilitation

Jain, E., Harmon, E. Y., & Sonagere, M. B. (2021) · PM&R · doi:10.1002/pmrj.12607 · Cited by 18

The impact of COVID-19 on accelerating of immunosenescence and brain aging

Müller, L., & Benedetto, S. D. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1471192 · Cited by 24

Introducing APOA1 as a key protein in COVID-19 infection: a bioinformatics approach.

Azodi, M. Z., Arjmand, B., Zali, A., & Razzaghi, M. R. (2020) · Gastroenterology and hepatology from bed to bench. · Cited by 17

Alterações Neurológicas Na Covid-19: Uma Revisão Sistemática

Nunes, M. J. M., Silva, J. C. S., de Oliveira, L. C., Marcos, G. V. T. D. M., Fernandes, A. C. L., Santos, W. L. D. S., Gúzen, F. P., Cavalcanti, J. R. L. D. P., & de Araújo, D. P. (2020) · Revista Neurociências · doi:10.34024/rnc.2020.v28.10949 · Cited by 17

Gastrointestinal disorders in post-COVID syndrome. Clinical guidelines

Grinevich, V. B., Лазебник, Л. Б., Kravchuk, Y. A., Радченко, В. Г., Ei, T., Першко, А. М., Seliverstov, P. V., Salikova, S. P., Zhdanov, K. V., Kozlov, K. V., et al. (2023) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-208-12-4-68 · Cited by 20

Long-term cognitive dysfunction after the COVID-19 pandemic: a narrative review

Shariff, S., Uwishema, O., Mizero, J., Thambi, V. D., Nazir, A., Mahmoud, A., Kaushik, I., Khayat, S., Maigoro, A. Y., Awde, S., et al. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001265 · Cited by 19

Prevalence Estimates and Risk Factors of Anxiety among Healthcare Workers in Jordan over One Year of the COVID-19 Pandemic: A Cross-Sectional Study

Yassin, A., Al-Mistarehi, A.-H. W., El‐Salem, K., Karasneh, R. A., Al-Azzam, S. I., Qarqash, A., Khasawneh, A. G., Alaabdin, A. M. Z., & Soudah, O. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19052615 · Cited by 17

Cognitive impairments in patients with subacute coronavirus disease: Initial experiences in a post-coronavirus disease clinic

Chang, J. G., Ha, E.-H., Lee, W., & Lee, S. Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.994331 · Cited by 17

Possible immunity, inflammation, and oxidative stress mechanisms of Alzheimer’s disease in COVID-19 patients

Wang, H., Qin, R., Zhang, J., & Chen, Y. (2020) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2020.106414 · Cited by 17

Neuropsychological disorders after COVID-19. Urgent need for research and clinical practice

Łojek, E., Egbert, A. R., Gambin, M., Gawron, N., Gorgol, J., Hansen, K., Holas, P., Hyniewska, S., Malinowska, E., Pluta, A., et al. (2021) · Postępy Psychiatrii i Neurologii · doi:10.5114/ppn.2021.108474 · Cited by 17

2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19

Bozkurt, B., Das, S. R., Addison, D., Gupta, A., Jneid, H. M., Khan, S. S., Koromia, G. A., Kulkarni, P. A., LaPoint, K., Lewis, E. F., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.03.355 · Cited by 17

Pandemia COVID-19. Perspektywa psychologiczna

(2022) · Wydawnictwo Liberi Libri eBooks · doi:10.47943/lib.9788363487607 · Cited by 15

Recent insights into viral infections as a trigger and accelerator in alzheimer's disease

Vlieger, L. D., Vandenbroucke, R. E., & Hoecke, L. V. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103340 · Cited by 16

Cortical GABA Levels Are Reduced in Post-Acute COVID-19 Syndrome

Marinković, K., White, D. R., Myers, A. A., Parker, K. S., Arienzo, D., & Mason, G. F. (2023) · Brain Sciences · doi:10.3390/brainsci13121666 · Cited by 17

Alzheimer’s disease and infectious agents: a comprehensive review of pathogenic mechanisms and microRNA roles

Hosseininasab, S. S. M., Ebrahimi, R., Yaghoobpoor, S., Kazemi, K., Khakpour, Y., Hajibeygi, R., Mohamadkhani, A., Fathi, M., Vakili, K. G., Tavasol, A., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1513095 · Cited by 20

Nanotargeting of Drug(s) for Delaying Dementia: Relevance of Covid-19 Impact on Dementia

D'Arrigo, J. S. (2020) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317520976761 · Cited by 16

Safety, Feasibility, and Outcomes of Frequent, Long-Duration Rehabilitation in an Inpatient Rehabilitation Facility After Prolonged Hospitalization for Severe COVID-19: An Observational Study

Vickory, F., Ridgeway, K. J., Falvey, J. R., Houwer, B., Gunlikson, J., Payne, K., & Niehaus, W. (2021) · Physical Therapy · doi:10.1093/ptj/pzab208 · Cited by 16

Neuromodulation through brain stimulation-assisted cognitive training in patients with post-COVID-19 cognitive impairment (Neuromod-COV): study protocol for a PROBE phase IIb trial

Thams, F., Antonenko, D., Fleischmann, R., Meinzer, M., Grittner, U., Schmidt, S. H., Brakemeier, E., Steinmetz, A., & Flöel, A. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-055038 · Cited by 17

Unveiling the Clinical Spectrum of Post-COVID-19 Conditions: Assessment and Recommended Strategies

Assiri, A. M., Alamaa, T., Elenezi, F., Alsagheir, A. I., Alzubaidi, L. M. Y., TIeyjeh, I., Alhomod, A. S., Gaffas, E. M., & Amer, S. A. (2024) · Cureus · doi:10.7759/cureus.52827 · Cited by 18

Long COVID in Children, Adults, and Vulnerable Populations: A Comprehensive Overview for an Integrated Approach

Calcaterra, V., Zanelli, S., Foppiani, A., Verduci, E., Benatti, B., Bollina, R., Bombaci, F., Brucato, A. L., Cammarata, S., Calabrò, E., et al. (2024) · Diseases · doi:10.3390/diseases12050095 · Cited by 17

Alzheimer’s disease in elderly COVID-19 patients: potential mechanisms and preventive measures

Wang, H., Lü, J., Zhao, X., Qin, R., Song, K., Xu, Y. Q., Zhang, J., & Chen, Y. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05616-1 · Cited by 15

Cognitive impairment associated with COVID-19: a literature review

Garcia, A. C. P., Meneses, A. C., Cavalcante, A. K. C., de Morais, C. R., Henz, G. D., Pessôa, G. R., & Fernandez, L. L. (2021) · doi:10.5327/1516-3180.683 · Cited by 1

Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: A delayed pandemic?

Serrano-Castro, P. J., Estivill‐Torrús, G., Cabezudo‐García, P., Bueno, J. A. R., Ciano-Petersen, N. L., Aguilar-Castillo, M. J., Suárez-Pérez, J., Jiménez-Hernández, M. D., Moya-Molina, M. Á., Oliver‐Martos, B., et al. (2020) · Neurología (English Edition) · doi:10.1016/j.nrleng.2020.04.002 · Cited by 82

COVID-19 and neurodegeneration: Perspectives on the impact of viruses on the brain

Luna-Tenorio, E., Torres-Mendoza, J. N., Franco-Colín, M., Álvarez‐González, I., de la Cruz‐López, F., Garcés‐Ramírez, L., & Luna‐Muñoz, J. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261434258

Inflammation at the crossroads of COVID-19, cognitive deficits and depression

Silva, N. M. L. E., Barros‐Aragão, F. G. Q., Felice, F. G. D., & Ferreira, S. T. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109023 · Cited by 96

Two-year trajectory of cognitive decline and neurological sequelae in COVID-19 survivors with acute neurological symptoms

Lin, J., Chen, S., Zhang, L., Qiu, M., Zuo, W., Wang, L., He, Q., Li, Y., Jin, H., Tan, S., et al. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1724803